GLP-1 receptor agonists

(085) An Assessment of Use and Comparative Safety of GLP-1 Receptor Agonists in the Real-world Setting, 2017-2023

(086) Applying Natural Language Processing of Clinical Notes to Determine Social Determinant Risk Factor Status for Patients Receiving Glucagon-Like Peptide-1 Agonist Treatment

(087) Assessment of the Long-Term Stability of Drug Safety Signals between Frequency and Bayesian-based methods for Glucagon-like Peptide-1 Receptor Agonists

(088) Association of Glucagon-Like Peptide-1 Receptor Agonists with Parkinson’s Disease: Scandinavian Cohort Study

(089) Characteristics of Glucagon-Like Peptide-1 Agonist Prescriptions for Weight Loss in the Real-World Setting

(090) Characteristics of Initial Prescription Dispensations Among Individuals Newly Prescribed GLP-1 Medications in a National Retail Pharmacy Database

(091) Characterizing the use of weight loss medications in people with obesity-related asthma in the All of Us Research Program

(093) Effectiveness of GLP-1 Receptor Agonists on Bodyweight Among Patients with Type-2 Diabetes Mellitus: Emulation of Five Randomized Clinical Trials Using Electronic Medical Records

(094) Effectiveness of the GLP-1 Receptor Agonists Approved to Manage Overweight and Obesity: An Emulation of the STEP 8 Trial Using Electronic Medical Records

(095) Gastrointestinal Adverse Events with Glucagon-like Peptide-1 Receptor Agonist in Type 2 Diabetes: A Comprehensive Meta-analysis of Randomised Controlled Trials and Refining Signals through Pharmacovigilance Analysis.

(096) GLP1 comparative effectiveness against dementia onset in a large, multi-site cohort of type 2 diabetes patients: a trial emulation approach with targeted learning

(097) Real-World Patterns in GLP-1 RA Switching from 2018-2023 in the US

(100) Trends in Clinical Characteristics and Prescribing Patterns for GLP-1 Receptor Agonists and GIPs, 2015–2023

(101) Use of SGLT2 inhibitors vs. GLP-1 RAs and Asthma Exacerbation in Patients with Diabetes and Asthma – A target Trial Emulation Study

(102) Utilization of drugs with weight loss effect in Norway 2017-2023